BioAssets Development's Unattributed VC Round

BioAssets Development raised a round of funding on September 08, 2009.

BioAssets Development Corporation (BDC) is working on indications for marketed and emerging biologic drugs. The company's lead initiative focuses on the development of cytokine inhibitors to treat the…

Articles about BioAssets Development's Unattributed VC Round: